DocGo outlines $310M-$315M 2026 revenue outlook while targeting 75% mobile phlebotomy growth
Source: SeekingAlpha
2026-05-12 01:53:15 ET
More on DocGo
- DocGo Inc. (DCGO) Q1 2026 Earnings Call Transcript
- DocGo Inc. (DCGO) Q4 2025 Earnings Call Transcript
- DocGo GAAP EPS of -$0.15, revenue of $75.6M
- DocGo outlines 2026 revenue guidance of $290M–$310M as company targets profitability and explores strategic alternatives
- Seeking Alpha’s Quant Rating on DocGo
Read the full article on Seeking Alpha
For further details see:
DocGo outlines $310M-$315M 2026 revenue outlook while targeting 75% mobile phlebotomy growth
DocGo Inc.
NASDAQ: DCGO
DCGO Trading
-2.65% G/L:
$0.5538 Last:
352,559 Volume:
$0.5666 Open:
DCGO Latest News
May 26, 2026 07:35:00 am
DocGo Announces Upcoming Participation at the Goldman Sachs 47th Annual Global Healthcare Conference
DCGO Stock Data
$74,289,256
94,096,464
2.9%
28
N/A
Healthcare Providers & Services
Healthcare
US
New York
